Methylation of H2AR29 is a Novel Repressive PRMT6 Target
Overview
Genetics
Authors
Affiliations
Background: Covalent histone modifications are central to all DNA-dependent processes. Modifications of histones H3 and H4 are becoming well characterised, but knowledge of how H2A modifications regulate chromatin dynamics and gene expression is still very limited.
Results: To understand the function of H2A modifications, we performed a systematic analysis of the histone H2A methylation status. We identified and functionally characterised two new methylation sites in H2A: R11 (H2AR11) and R29 (H2AR29). Using an unbiased biochemical approach in combination with candidate assays we showed that protein arginine methyltransferase (PRMT) 1 and PRMT6 are unique in their ability to catalyse these modifications. Importantly we found that H2AR29me2 is specifically enriched at genes repressed by PRMT6, implicating H2AR29me2 in transcriptional repression.
Conclusions: Our data establishes R11 and R29 as new arginine methylation sites in H2A. We identified the specific modifying enzymes involved, and uncovered a novel functional role of H2AR29me2 in gene silencing in vivo. Thus this work reveals novel insights into the function of H2A methylation and in the mechanisms of PRMT6-mediated transcriptional repression.
Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells.
Eudenbach M, Busam J, Bouchard C, Rossbach O, Zarnack K, Bauer U Life Sci Alliance. 2025; 8(4).
PMID: 39900436 PMC: 11791029. DOI: 10.26508/lsa.202402946.
The PRMT6/STAT1/ACSL1 axis promotes ferroptosis in diabetic nephropathy.
Hong J, Li X, Hao Y, Xu H, Yu L, Meng Z Cell Death Differ. 2024; 31(11):1561-1575.
PMID: 39134684 PMC: 11519485. DOI: 10.1038/s41418-024-01357-8.
Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease.
Zhang Y, Wei S, Jin E, Jo Y, Oh C, Bae G Diabetes Metab J. 2024; 48(4):487-502.
PMID: 39043443 PMC: 11307121. DOI: 10.4093/dmj.2023.0362.
Dysregulation of arginine methylation in tumorigenesis.
Li X, Song Y, Mu W, Hou X, Ba T, Ji S Front Mol Biosci. 2024; 11:1420365.
PMID: 38911125 PMC: 11190088. DOI: 10.3389/fmolb.2024.1420365.
Yu P, Xu T, Ma W, Fang X, Bao Y, Xu C J Exp Clin Cancer Res. 2024; 43(1):116.
PMID: 38637831 PMC: 11025288. DOI: 10.1186/s13046-024-03038-3.